Newsroom - DRIVE

NewsroomRoberto Bonaiuti2021-03-23T09:43:22+01:00

News releases

Launch of an ambitious cross-pharma study by the public-private partnership ‘COVIDRIVE’: a multi-country European study to continuously monitor COVID-19 vaccine effectiveness against severe disease

DRIVE patient groups involvement initiative

New Public-private Partnership COVIDRIVE To Assess brand-specific COVID-19 Vaccine Effectiveness In Europe

What factors drive choices between types and brands of influenza vaccines in general practice in Europe?

DRIVE celebrates its first Inter-work package workshop to strengthen the project’s internal communications

Results from the DRIVE EU study platform 2019/20 published in Vaccine

New DRIVE publication in PLOS One: Investigating the procurement system for understanding seasonal influenza vaccine brand availability in Europe

DRIVE conducts the first IVE estimations in a primary care sentinel surveillance using network with POCT machines

Call for tenders 2021/2022 – DRIVE invites study sites interested in researching influenza vaccine effectiveness to join the network – apply now!

DRIVE testimonies: Alexandre Descamps, on the participation of INSERM as DRIVE consortium partner and study site

Challenges and Adaptation of a European Influenza Vaccine Effectiveness Study Platform in Response to COVID-19: Experience from the DRIVE Project

DRIVE brainstorming sessions: opening up possibilities

Public-private Brainstorming 2020 – Session two

Public-private Brainstorming 2020 – Session one

ESCAIDE 2020, abstract and full presentation

DRIVE showcases 2019/20 results at ESWI 2020

DRIVE presents results at ESCAIDE 2020

DRIVE sponsored study published by Oxford University

3rd DRIVE Annual Forum: interventions from representatives of the major institutions studying Influenza Vaccine Effectiveness

Results from the DRIVE network during season 2018/19 published in “Vaccine”

3rd DRIVE Annual Forum 2020

DRIVE Annual Forum webinars for stakeholders on the 22th and 24th of September: Brand-specific influenza vaccine effectiveness and COVID-19 impact on influenza season

DRIVE Annual Forum Webinars 2020 – Save the dates: 22 & 24 September

DRIVE sponsored study in Finland reveals significant differences in clinical characteristics of patients with COVID-19 and influenza

DRIVE sponsored study in UK featured by BJGP

DRIVE at the 16th World Congress on Public Health 2020

ECCMID Abstract

Call for tenders’ deadline – Postponed

DRIVE’s June Annual Forum – Cancelled

DRIVE Project official statement on current COVID-19 situation

VAHNSI interview and sites feedback

DRIVE Coordinator invites Research Collaborators to join the network

DRIVE: Call for Research Collaborators to Join New Efforts to Study Brand-specific Influenza

Call for tenders 2020/2021 – DRIVE invites study sites interested in researching influenza vaccine effectiveness to join the network – apply now!

Influenza vaccine effectiveness against laboratory-confirmed influenza in Europe: results from DRIVE network 2018/19

DRIVE Annual Forum, Brussels, 24-25 June 2020

DRIVE visits news sites: France, Spain and Luxembourg

Public-private Brainstorming in Paris

DRIVE publishes study results for the 2018/19 influenza season on its website

DRIVE’s Annual Forum 2019: A success!

Nine new sites will join DRIVE this season!

DRIVE Annual Forum, Helsinki, 17-18 July 2019

Report on study platform governance implementation and adaptation – Lessons learnt from the first season implementation and adaptations for the next seasons

“Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe” published at Vaccine

DRIVE SAP 2018/19 and DRIVE network posted to ENCePP registers

Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe

DRIVE: Call for Researchers to Join New Efforts to Study Brand-specific Influenza

Call for tenders 2019/2020 – DRIVE invites study sites capable of researching influenza vaccine effectiveness to join the network – apply now!

DRIVE report: Feasible, novel and innovative approaches for measuring influenza vaccine effectiveness

DRIVE presents study during 11th European Public Health Conference

DRIVE at the 10th H2020 Conference in Toledo

Call for study sites capable of researching influenza vaccine effectiveness – join the European research network DRIVE

DRIVE pilot study published

DRIVE at ESCAIDE 2018 – Presentations on register-based cohort studies, European vaccine procurement systems and public-private collaboration governance

DRIVE presentation at ESCAIDE: Seasonal flu vaccines come in multiple flavours: DRIVE wants to know, which brands are used and where?

Attend the DRIVE Webinar on November the 16 at 10.00 CET

Highlights of the DRIVE Annual Forum: how to tackle the challenge of analysing brand-specific influenza vaccine effectiveness?

DRIVE Annual Forum – Rome, 17.-18. September

Open for comments: a European research agenda to address knowledge gaps on influenza vaccine effectiveness

DRIVE invites study sites capable of researching influenza vaccine effectiveness to join the network – apply now!

Call for tenders – 2018/2019 influenza season

DRIVE is searching for new collaborators for the next influenza season – join us to develop robust tools to measure influenza vaccine effectiveness

DRIVE Officially Launched

DRIVE presented at ESCAIDE 2017

Media Resources

Brand-specific influenza vaccine effectiveness: Setting up studies in Europe, season 2017-2018 – Lay summary for media and the general public

DRIVE Executive summary – Establishing brand-specific influenza vaccine effectiveness studies in Europe, 2017/18 season

About Influenza Fact Sheet

About DRIVE Fact Sheet

Media Contact

Media contact:

Riikka Rossi
Development manager
Finnish Institute for Health and Welfare (THL)
riikka.rossi@thl.fi